Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins

Biochem Biophys Res Commun. 2000 Apr 29;271(1):15-21. doi: 10.1006/bbrc.2000.2530.

Abstract

The C-terminal domain of lipoprotein lipase (LPL) is involved in several important interactions. To assess its contribution to the binding ability of full-length LPL we have determined kinetic constants using biosensor technique. The affinity of the C-terminal domain for heparin was about 500-fold lower than that of full-length LPL (K(d) = 1.3 microM compared to 3.1 nM). Replacement of Lys403, Arg405 and Lys407 by Ala abolished the heparin affinity, whereas replacement of Arg420 and Lys422 had little effect. The C-terminal domain increased binding of chylomicrons and VLDL to immobilized heparin relatively well, but was less than 10% efficient in binding of LDL compared to full-length LPL. Deletion of residues 390-393 (WSDW) did not change the affinity to heparin and only slightly decreased the affinity to lipoproteins. We conclude that the C-terminal folding domain contributes only moderately to the heparin affinity of full-length LPL, whereas the domain appears important for tethering triglyceride-rich lipoproteins to heparin-bound LPL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Dose-Response Relationship, Drug
  • Heparin / metabolism*
  • Heparitin Sulfate / metabolism
  • Ions
  • Kinetics
  • Lipoprotein Lipase / chemistry*
  • Lipoprotein Lipase / metabolism*
  • Lipoproteins / metabolism*
  • Protein Binding
  • Protein Structure, Tertiary
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Sodium Chloride / metabolism
  • Spectrometry, Fluorescence
  • Surface Plasmon Resonance
  • Time Factors

Substances

  • Ions
  • Lipoproteins
  • Recombinant Proteins
  • Sodium Chloride
  • Heparin
  • Heparitin Sulfate
  • Lipoprotein Lipase